NCI Bid For New Clinical Review Panel Rejects; But Invites Researchers To ‘Submit Best Ideas’
In Brief: NSABP Proposal Selected for Tamoxifen Trials; NIH Building To Be Named After Silvio Conte
DCT Advisors OK 2 Grant Programs, Disapprove One, In NCI Effort To Improve Funding For Clinical Research
NHLBI Advisers Commit Funding TO NCI’s Women’s Health Trials, Tamoxifen Trial
Cancer Prevention Fellowship Program Offers Enhancement
Trending Stories
- The story of daraxonrasib is the ultimate hero’s journey
A narrative curve with twists, turns, intrigue, drama—and a blow to a mighty foe - At Senate hearing, Brown’s El-Deiry and other witnesses say they were targeted for arguing that mRNA vaccine may be linked to cancer
- Pancreatic cancer breakthrough came from smart scientists making smart bets—not from politicization of science
- Pancreatic cancer finally starts to budge as daraxonrasib doubles overall survival
- As his Senate testimony alleged danger from mRNA COVID vaccine, El-Deiry had an offer to run NCI Frederick lab
The job offer to run the lab—home to virus research, RAS Initiative, and data science—was quickly rescinded - Political appointees to be inserted into all stages of making research funding awards if OMB rule becomes final









